Yarden, Yosef

Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor

Enuka, Y., Lauriola, M., Feldman, M. E., Sas-Chen, A., Ulitsky, I., & Yarden, Y. (2016) · Nucleic Acids Research

Circular RNAs in diseasesRNA Research and Splicing

Cited by 757

Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor

Yarden, Y., & Schlessinger, J. (1987) · Biochemistry

HER2/EGFR in Cancer ResearchReceptor Mechanisms and Signaling

Cited by 627

EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance

Uribe, M. L., Marrocco, I., & Yarden, Y. (2021) · Cancers

HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations

Cited by 604

Isolation of the NeuHER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cells

Peles, E., Bacus, S. S., Koski, R. A., Lu, H. S., Wen, D., Ogden, S. G., Levy, R. B., & Yarden, Y. (1992) · Cell

HER2/EGFR in Cancer ResearchLiver physiology and pathology

Cited by 524

The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors

Klapper, L. N., Glathe, S., Vaisman, N., Hynes, N. E., Andrews, G. C., Sela, M., & Yarden, Y. (1999) · Proceedings of the National Academy of Sciences

HER2/EGFR in Cancer ResearchLiver physiology and pathology

Cited by 455

Signal transduction and oncogenesis by ErbB/HER receptors

Marmor, M. D., Skaria, K. B., & Yarden, Y. (2004) · International Journal of Radiation Oncology*Biology*Physics

HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations

Cited by 389